companydata.dkBioMed Invest ApS: Financial statements 2018
CVR: 29844925
BioMed Invest ApS (CVR 29844925) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -35,182 and a net result of DKK -15,834 compared with DKK -182,822 the year before. Equity amounted to DKK 1,527,041. The solvency ratio was 94%.
- Gross Profit
- -35,182 kr.
- Profit/Loss
- -15,834 kr.
- Equity
- 1,527,041 kr.
- Total Assets
- 1,624,193 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -35 t. | -16 t. | 1.5 mio. | - |
| 2017 | - | 137 t. | -183 t. | 1.6 mio. | - |
| 2016 | - | 77 t. | -771 t. | 1.9 mio. | - |
| 2015 | - | - | 218 t. | 2.7 mio. | - |
| 2014 | - | 72 t. | 708 t. | 2.6 mio. | - |
Keep an eye on BioMed Invest ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
BioMed Invest ApS has published its annual report for 2017. Gross profit came to DKK 136,530, and the net result was DKK -182,822.
About BioMed Invest ApS
BioMed Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2006. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Erling Henningsen. The company is owned by Erling Henningsen. In 2025, the company reported a gross profit of DKK 12,474 and a net result of DKK -80,320 compared with DKK 451,303 the year before. Equity amounted to DKK 8,740,167.